scispace - formally typeset
Open AccessJournal ArticleDOI

Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.

Reads0
Chats0
TLDR
EBV LMP appears to be a mediator of EBV effects on B-cell transformation and may result in more effective T-cell immune surveillance, since cytoskeletal association may be integral to LMP activity.
Abstract
A latent infection membrane protein (LMP) encoded by the Epstein-Barr virus (EBV) genome in latently infected, growth-transformed lymphocytes alters the phenotype of a human EBV-negative B-lymphoma cell line (Louckes) when introduced by gene transfer. These LMP-expressing cells exhibit increased homotypic adhesion due to increased expression of the adhesion molecules LFA-1 and ICAM-1. Increased homotypic adhesion could foster B-cell growth by facilitating autocrine growth factor effects. LFA-3 expression is also induced. The induction of LFA-3 and ICAM-1 results in increased heterotypic adhesion to T lymphocytes. This could result in more effective T-cell immune surveillance. Since LMP is expressed in EBV-transformed lymphocytes and has been demonstrated to transform rodent fibroblasts in vitro, a wide range of possible effects on B-lymphoma cell growth were assayed. In the Louckes B-lymphoma cell line, EBV LMP causes increased cell size, acid production, plasma membrane ruffling, and villous projections. Although cell proliferation rate was not greatly affected, the steady-state intracellular free calcium level, transforming growth factor beta responsiveness, and expression of the lymphocyte activation markers (CD23 and transferrin receptor) were increased. Thus, LMP appears to be a mediator of EBV effects on B-cell transformation. In transfected lymphoma cells, LMP localizes to patches at the cell periphery and associates with the cytoskeleton as it does in EBV-transformed B lymphocytes or in rodent fibroblasts. A partially deleted form of LMP (D1LMP) does not aggregate in patches or associate with the cytoskeleton and had little effect on B-cell growth. Thus, cytoskeletal association may be integral to LMP activity.

read more

Citations
More filters
Journal ArticleDOI

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.

TL;DR: By DNA transfection into human B cells, it is shown that protection from apoptosis is conferred through expression of a single EBV latent protein, the latent membrane protein LMP 1, and it is demonstrated that L MP 1 mediates this effect by up-regulating expression of the cellular oncogene bcl-2.
Journal ArticleDOI

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

TL;DR: The interaction of LMP1 with these TNFR family-associated proteins is further evidence for their role in signaling and links L MP1-mediated transformation to signal transduction from the TNFRfamily.
Journal ArticleDOI

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.

TL;DR: Using monoclonal antibody-immune microscopy, it is demonstrated that these two EBV proteins and their associated B-lymphocyte activation or adhesion molecules are expressed in the infiltrating B lymphocytes in immunocompromised patients with EBV lymphoproliferative disease.
Journal ArticleDOI

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

TL;DR: LMP1 is essential for EBV-mediated transformation of primary B lymphocytes, that the first 43 amino acids are critical for LMP1's function, and that codon 44-initiated L MP1 does not have a dominant negative effect on transformation.
Journal ArticleDOI

Epstein-Barr Virus and Cancer

TL;DR: EBV was the first human virus to be directly implicated in carcinogenesis and recent advances in antiviral therapeutics, application of monoclonal antibodies, and generation of EBV-specific CTLs are beginning to show promise in the treatment ofEBV-related disorders.
References
More filters
Journal ArticleDOI

Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1)

TL;DR: The purified ICAM-1 was incorporated into artificial supported lipid membranes and required metabolic energy production, an intact cytoskeleton, and the presence of Mg2+ and was temperature dependent, characteristics of LFA-1- and ICAM -1-dependent cell-cell adhesion.
Journal Article

A human intercellular adhesion molecule (icam-1) distinct from lfa-1

TL;DR: It is proposed that ICAM-1 may be a ligand in many, but not all, LFA-1-dependent adhesion reactions.
Journal ArticleDOI

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells

TL;DR: This is the first demonstration of a transforming gene in Epstein-Barr virus, a ubiquitous human pathogen associated with neoplasia, which is likely to account for many aspects of EBV induced cell transformations.
Journal ArticleDOI

The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system.

TL;DR: This review focuses on LFAI, CD2, and LFA-3, which appear to enhance antigen-specific functions by acting as cell adhesion molecules and the role of CD4 and CD8 is reviewed by Littman.
Journal ArticleDOI

Synergistic induction of mesoderm by FGF and TGF-β and the identification of an mRNA coding for FGF in the early xenopus embryo

TL;DR: It is shown that bovine basic FGF has a limited capacity to induce muscle actin expression in animal hemisphere cells, and it is suggested that molecules closely related to FGF and TGF-beta are the natural inducers of mesoderm in vertebrate development.
Related Papers (5)